Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) LT-Debt-to-Total-Asset : 0.03 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Jiuzhou Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Zhejiang Jiuzhou Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.03.

Zhejiang Jiuzhou Pharmaceutical Co's long-term debt to total assets ratio increased from Mar. 2023 (0.02) to Mar. 2024 (0.03). It may suggest that Zhejiang Jiuzhou Pharmaceutical Co is progressively becoming more dependent on debt to grow their business.

Zhejiang Jiuzhou Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Zhejiang Jiuzhou Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jiuzhou Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Zhejiang Jiuzhou Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.11

0.03

0.01

0.04

Zhejiang Jiuzhou Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.02	0.02	0.03	0.04	0.03

Zhejiang Jiuzhou Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Zhejiang Jiuzhou Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	400.945	/	10851.987
	=	0.04

Zhejiang Jiuzhou Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	409.793	/	12249.806
	=	0.03

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Zhejiang Jiuzhou Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Zhejiang Jiuzhou Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jiuzhou Pharmaceutical Co Ltd (SHSE:603456) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang, CHN, 318000

Website

http://www.jiuzhoupharma.com

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.

Executives

Sha Yu Jie	Directors, senior managers
Mei Yi Jiang	Director
Li Yuan Qiang	senior management
Yang Nong Gang	senior management
	Directors, senior managers
Huang Min Xia	senior management
Wang Bin	Directors, senior managers
Dai Yun You	senior management
Jiang Zu Lin	Directors, senior managers
Guo Zhen Rong	senior management
Chen Zhi Hong	Directors, senior managers
Xu Jia Jun	Supervisors
Hua Li Rong	Director
Lin Hui Lu	senior management
Zhu Guo Liang	Supervisors

Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Headlines

No Headlines